Research output per year
Research output per year
Personal profile
Expertises
Prostate Cancer; Chemotherapy; Immunotherapy
Main research areas
Treatment outcomes in daily clinical practice; The application of docetaxel and cabazitaxel in general practice; Predictors of chemotherapy induced toxicity; Prostate cancer and the immune system; Immunotherapy in prostate cancer; Dendritic cell vaccination; Peptide vaccination; Combination therapy; Biomarkers in metastatic castration-resistant prostate cancer (mCRPC); Circulating tumor cells in mCRPC
Current research
PhD thesis entitled: "Taxane-based chemotherapy and dendritic cell therapy in metastatic castration-resistant prostate cancer".
Peptide vaccination in metastatic prostate cancer; Characterization of stromal cells in prostate cancer; Circulating tumor cells in mCRPC
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Per Kongsted is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R. & Thor Straten, P. & 2 others, , 14 Mar 2023, In: Frontiers in Immunology. 14, 15 p., 1122977.Research output: Contribution to journal › Journal article › Research › peer-review
-
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., Pedersen, M., Nielsen, M., Kjeldsen, J. W., Kverneland, A. H., Lauss, M., Hölmich, L. R., Hendel, H., Met, Ö., Jönsson, G., Donia, M. & Marie Svane, I., Jul 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, e002703.Research output: Contribution to journal › Journal article › Research › peer-review
10 Citations (Scopus) -
T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression
Andersen, R., Borch, T. H., Draghi, A., Gokuldass, A., Rana, A. H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J. W., Westergaard, M. C. W., Radic, H. D., Chamberlain, C. A., Hölmich, L. R., Hendel, H. W., Larsen, M. S., Met, Ö., Svane, I. M. & Donia, M., 1 Jul 2018, In: Annals of Oncology. 29, 7, p. 1575-1581 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
51 Citations (Scopus) -
13PD T cell responses in patients with melanoma resistant to multiple immunotherapies
Andersen, R., Borch, T. H., Draghi, A., Gokuldass, A., Rana, A. H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J. W., Westergaard, M. C. W., Hølmich, L. R., Hendel, H. W., Larsen, M. S., Met, Ö., Svane, I. M. & Donia, M., 11 Dec 2017, In: Annals of Oncology. 28, supplResearch output: Contribution to journal › Journal article › Research › peer-review
-
Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer
Kongsted, P., Svane, I. M., Lindberg, H. & Sengeløv, L., Apr 2017, In: Clinical Genitourinary Cancer (Online). 15, 2, p. e281-287Research output: Contribution to journal › Journal article › Research › peer-review
5 Citations (Scopus)